drugset
Drugs / Hyperpolarized Carbon C 13 Pyruvate
last change Oct 2024 re-read 3 minutes ago

Hyperpolarized Carbon C 13 Pyruvate

Diagnostic / imaging agent

Investigated by
National Cancer Institute (NCI) · M.D. Anderson Cancer Center · National Institute for Biomedical Imaging and Bioengineering (NIBIB) · Zhen Wang, MD · American Cancer Society, Inc. · Daniel M. Spielman
+8 more · GE Healthcare · General Electric · Javier Villaneuva-Meyer, MD · National Institutes of Health (NIH) · Phillips-Medisize · Sigma-Aldrich · Susan Chang · University of California, San Francisco

Trials 9

today NCT06014905 · Ph 1 NCT04565327 · Ph 2 NCT04589624 · Ph 1 NCT03830151 · Ph 1 NCT03581500 · Ph 2 NCT04258462 · Ph 2 NCT03565367 · Ph 1 NCT03933670 · Ph 2 NCT04540107 · Ph 1
2017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 15 trials
Phase 1 NCT06014905 Sep 2023 → Sep 2027 expected meningioma Javier Villaneuva-Meyer, MD Recruiting No outcome recorded
Phase 1 NCT04589624 Aug 2020 → May 2027 expected thyroid gland carcinoma M.D. Anderson Cancer Center Recruiting No outcome recorded
Phase 1 NCT03830151 May 2019 → Dec 2028 expected primary brain neoplasm M.D. Anderson Cancer Center Recruiting No outcome recorded
Phase 1 NCT03565367 Nov 2018 → Jun 2019 central nervous system cancer Daniel M. Spielman Completed No outcome recorded
Phase 1 NCT04540107 Jan 2017 → Jan 2027 expected grade II glioma, grade III glioma Susan Chang Recruiting No outcome recorded
Phase 24 trials
Phase 2 NCT04565327 Aug 2020 → Nov 2022 pancreatic ductal adenocarcinoma Zhen Wang, MD Terminated No outcome recorded Stop: Enrollment
Phase 2 NCT03581500 Feb 2019 → Oct 2024 prostate adenocarcinoma M.D. Anderson Cancer Center Withdrawn No outcome recorded
Phase 2 NCT04258462 Jan 2019 → Oct 2026 expected kidney benign neoplasm, renal cell carcinoma Zhen Wang, MD Active not recruiting No outcome recorded
Phase 2 NCT03933670 Jul 2018 → Dec 2027 expected prostate adenocarcinoma University of California, San Francisco Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as Hyperpolarized Carbon C 13 Pyruvate ClinicalTrials.gov intervention name — accepted as the source's own label NCT04565327 ↗
8

NCT03565367 ↗

NCT03581500 ↗

NCT04258462 ↗

NCT03830151 ↗

NCT03933670 ↗

NCT06014905 ↗

NCT04589624 ↗

NCT04540107 ↗
Modality Diagnostic / imaging agent “hyperpolarized carbon C 13 pyruvate magnetic resonance imaging may be used to measure the metabolic state of malignant brain tumors” NCT03565367 ↗
Route Intravenous “Given IV” NCT03565367 ↗